Imaging for decisions in drug development

Ground-breaking imaging for drug development is at the heart of what we do. Equally important is our extensive expertise in drug development and disease biology. This important mix of capabilities allows us to discuss and advise on study-design and to deliver clinical imaging studies addressing relevant biology.

We deliver vital insights that few others can offer – allowing our partners to make the right decisions for clinical programmes. In close partnership with both big pharma companies and biotechs, we create solutions delivered as innovative, complex mechanistic studies as well as large-scale, global, multi-centre imaging trials. Always tailoring our imaging solutions to facilitate decision-making.